Erlotinib as Frontline Treatment for Elderly Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) and Non-Squamous Histology - Results of a Galician Lung Cancer Group (GGCP044/09 Study) Grupo Galego De Cancro De Pulmon (GGCP)

被引：0
|
作者：
Firvidal, J. L. [1 ]
Vazquez, S. [2 ]
Casal, J. [3 ]
Fernandez, A. [1 ]
Varela, S. [2 ]
Villanueva, M. J. [3 ]
Perez, E. [1 ]
Campos, B. [2 ]
Salgado, M. [1 ]
Mel, J. R. [2 ]
机构：
[1] Complexo Hosp Ourense, Orense, Spain
[2] Hosp Lucus Augusti, Lugo, Spain
[3] Univ Vigo, Complexo Hosp, Vigo 36310, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72400-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S619 / S619
页数：1
相关论文
共 50 条
  • [31] Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer: a retrospective analysis
    Tian, Yaru
    Tian, Hairong
    Zhai, Xiaoyang
    Zhu, Hui
    Yu, Jinming
    FRONTIERS OF MEDICINE, 2022, 16 (04) : 610 - 617
  • [32] Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer: a retrospective analysis
    Yaru Tian
    Hairong Tian
    Xiaoyang Zhai
    Hui Zhu
    Jinming Yu
    Frontiers of Medicine, 2022, 16 : 610 - 617
  • [33] Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer: a retrospective analysis
    Tian Yaru
    Tian Hairong
    Zhai Xiaoyang
    Zhu Hui
    Yu Jinming
    Frontiers of Medicine, 2022, 16 (04) : 610 - 617
  • [34] Carboplatin-Pemetrexed Combination in Elderly Patients with Advanced Non-Squamous Non Small Cell Lung Cancer (NS-NSCLC)
    Vazquez, Sergio
    Carmen Areses, Maria
    Nunez, Natalia F.
    Alonso Herrero, Ana
    Covela Rua, Marta
    Villanueva Silva, Maria J.
    Afonso-Afonso, Francisco J.
    Esquerdo Galiana, Gaspar
    Lazaro Quintela, Martin
    Garcia Mata, Jesus
    Anido Herranz, Urbano
    Casal Rubio, Joaquin
    Firvida Perez, Jose L.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S657 - S657
  • [35] TOLERANCE AND EFFICACY OF CHEMOTHERAPY WITH PLATINUM AND PEMETREXED IN ELDERLY PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Leprieur, Etienne Giroux
    Labrune, Sylvie
    Giraud, Violaine
    Gendry, Thierry
    Cobarzan, Daniel
    Chinet, Thierry
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1285 - S1286
  • [36] Prolgolimab with chemotherapy as first-line treatment for advanced non-squamous non-small-cell lung cancer
    Laktionov, K.
    Smolin, A.
    Stroyakovskiy, D.
    Moiseenko, V.
    Dvorkin, M.
    Andabekov, T.
    Cheng, Y.
    Liu, B.
    Kozlov, V.
    Odintsova, S.
    Dvoretsky, S.
    Mochalova, A.
    Urda, M.
    Yi, T.
    Li, X.
    Laszlo, U.
    Mueller, V.
    Bogos, K.
    Fadeeva, N.
    Musaev, G.
    Liu, Q.
    Kirtbaya, D.
    Shi, J.
    Gladkov, O.
    Narimanov, M.
    Semiglazova, T.
    Khasanova, A.
    Chovanec, J.
    Andrasina, I
    Szabova, A.
    Rosinska, O.
    Sudekova, D.
    Zsolt, P. -s.
    Ran, F.
    Sun, M.
    Jiang, O.
    Chen, R.
    Zhao, E.
    Liu, C.
    Tan, W.
    Pirmagomedov, A.
    Poddubskaya, E.
    Kislov, N.
    Shumskaya, I.
    Sorokina, I.
    Zinkina-Orikhan, A.
    Linkova, Yu.
    Fogt, S.
    Liaptseva, D.
    Siliutina, A.
    EUROPEAN JOURNAL OF CANCER, 2025, 217
  • [37] Paclitaxel-bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study
    Bilger, Geoffroy
    Toffart, Anne-Claire
    Darrason, Marie
    Duruisseaux, Michael
    Ulmer, Lucie
    Wang, Pascal
    Leprieur, Etienne Giroux
    Girard, Nicolas
    Massiani, Marie Ange
    Bore, Paul
    Descourt, Renaud
    Pinsolle, Julian
    Valery, Solene
    Monnet, Isabelle
    Swalduz, Aurelie
    Tissot, Claire
    Fournel, Pierre
    Baranzelli, Anne
    Cortot, Alexis B.
    Decroisette, Chantal
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [38] A Galician Lung Cancer Group phase II study of bevacizumab (B), cisplatin, and vinorelbine in chemotherapy-naive patients (p) with non-squamous non-small cell lung cancer (NSCLC)
    Leon, L.
    Vazquez, S.
    Gracia, J.
    Casal, J.
    Lazaro, M.
    Firvida, J. L.
    Amenedo, M.
    santome, L.
    Cardona, J. V.
    Macia, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study
    Giaccone, Giuseppe
    Ruiz, Marielle Gallegos
    Le Chevalier, Thierry
    Thatcher, Nick
    Smit, Egbert
    Rodriguez, Jose Antonio
    Janne, Pasi
    Oulid-Aissa, Dalila
    Soria, Jean-Charles
    CLINICAL CANCER RESEARCH, 2006, 12 (20) : 6049 - 6055
  • [40] A single centre experience of pembrolizumab combination therapy in untreated advanced non-squamous non-small-cell lung cancer (NSCLC)
    Cox, N.
    Walther, J.
    Botten, J.
    Jankowska, P.
    LUNG CANCER, 2020, 139 : S56 - S57
12345